BIOMAT Database Logo BIOMAT Database Logo

Low-calcium dialysate worsens secondary hyperparathyroidism. 1996

A Argilés, and C M Mion

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015312 Hemodialysis Solutions Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers (e.g., acetate or carbonate), the addition of cations (Na+, K+, Ca2+), and addition of carbohydrates (glucose). Solutions, Hemodialysis,Dialysis Solutions, Hemodialysis,Hemodialysates,Hemodialyzates,Hemodialysis Dialysis Solutions,Solutions, Hemodialysis Dialysis

Related Publications

A Argilés, and C M Mion
Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism.
July 1995, Journal of the American Society of Nephrology : JASN,
A Argilés, and C M Mion
Low calcium dialysate and hyperparathyroidism.
January 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
A Argilés, and C M Mion
Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients?
January 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
A Argilés, and C M Mion
Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
January 1997, Mineral and electrolyte metabolism,
A Argilés, and C M Mion
Ovariectomy worsens secondary hyperparathyroidism in mature rats during low-Ca diet.
March 2007, American journal of physiology. Endocrinology and metabolism,
A Argilés, and C M Mion
Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients.
January 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Argilés, and C M Mion
[Low calcium dialysate].
December 1991, Nihon rinsho. Japanese journal of clinical medicine,
A Argilés, and C M Mion
[Low calcium dialysate].
December 1991, Nihon rinsho. Japanese journal of clinical medicine,
A Argilés, and C M Mion
Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
June 1993, Kidney international. Supplement,
A Argilés, and C M Mion
Low-calcium dialysate and dosage of calcium carbonate.
February 1996, Journal of the American Society of Nephrology : JASN,
Copied contents to your clipboard!